HCG is introduced

PreclinicalSmall molecule

SServy Massey Fertility Insititute

HCG is introduced is one of 8 small molecule programs targeting Embryo Transfer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Embryo TransferCompleted

Embryo TransferPreclinical

Completed

Competition

Competitive Landscape

7 competitors in Embryo Transfer

#DrugCompanyPhaseTrials

Gnrh Agonist

Johnson & Johnson

Phase 3

3 2

Hcg

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3

3 3

Ketorolac IV

IIslamabad Medical and Dental College

Phase 3

1 4

Tractocile

GSK

Preclinical

1 5

Clomid

EMD Serono

Preclinical

1 6

Gnrh Ant

Merck & Co.

Preclinical

1 7

HCG is introduced

SServy Massey Fertility Insititute

Preclinical

1 8

The Platelet Rich Plasma（prp）

PPeking University Third Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Embryo Transfer1 trial

Injection of Hormone to Enhance Implantation in Embryo Transfer After IVF

Completed·SServy Massey Fertility Insititute·N/A·NCT01986374·75 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for HCG is introduced. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — HCG is introduced compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for HCG is introduced. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Servy Massey Fertility Insititute company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SServy Massey Fertility Insititute

HCG is introduced

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Embryo Transfer1 trial

References

Drug Info

Quick Facts

Related News